The main goal of the proposal is to understand the role of Hepatocyte Growth Factor (HGF), its receptor (cMet) and the hepatic biomatrix as determinants of hepatic growth, regeneration, tissue differentiation and neoplasia. Converging studies from our lab and others have identified HGF and matrix as key parameters in all these processes. Based on previous work, we have identified different roles and sources for HGF for the first 3 hours after partial hepatectomy (PHx), primarily from pre-existing matrix stores, and following 3 hours after PHx, primarily from newly synthesized HGF. Animal (rat and mouse) models, including conditional homozygous deletion of hepatic HGF gene, are to be employed to study the functions of HGF in liver regeneration. The same models will also be employed to understand the role of hepatic HGF during development of hepatic neoplasia. New HGF at 3 hours post PHx is synthesized not only in liver but also in remote sites. Since we found that norepinephrine stimulates synthesis of new HGF and also rises in the plasma after PHx, will pursue studies to explore the role of norepinephrine as the messenger for HGF synthesis throughout the body after PHx. In studies from the previous period we found that beta-catenin is subjected to tyrosine phosphorylation by cMet. We also now have evidence that beta-catenin is a key regulator of the early stages after PHx and it is subjected to tyrosine phosphorylation by cMet. Studies are proposed to understand the interaction between cMet and beta-catenin, including transgenic mice in which beta-catenin is expressed under the albumin promoter. Since beta-catenin mutations are important in liver cancer in humans, the proposed studies will provide information on the function of beta-catenin and its interaction with cMet as regulators of hepatic neoplasia. We have designed organoid cultures in which HGF, EGF and corticosteroids interact in a complex medium (HGM) to allow growth of hepatocytes and non-parenchymal cells, so that they form reproducible and recognizable structures of hepatic histology in a completely defined environment. We have found that corticosteroids and HGF are essential for hepatocyte maturation. HGF and EGF are essential for formation of the complex connective tissue and the fully mature biliary epithelium seen in these cultures. This system allows development biology studies impossible in mouse genetic systems. Proposed studies aim to use this """"""""in vitro embryology"""""""" system and provide answers on the role of HGF and matrix in hepatic tissue development and differentiation. Finally, we have succeeded in isolating relatively pure material on a key transcription factor (HNFx, for the purposes of the grant) that appears to regulate matrix- and HGF-induced hepatocyte differentiation in culture. Preliminary studies suggest that HNFx is related or identical to Ear2 transcription factor. Studies are described to determine the nature of HNFx and its regulation by growth factors and matrix during hepatocyte differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA035373-20
Application #
6430739
Study Section
Special Emphasis Panel (ZRG1-PTHC (02))
Program Officer
Freeman, Colette S
Project Start
1983-07-15
Project End
2007-12-31
Budget Start
2002-01-01
Budget End
2002-12-31
Support Year
20
Fiscal Year
2002
Total Cost
$327,739
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Bhushan, Bharat; Stoops, John W; Mars, Wendy M et al. (2018) TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation Are Attenuated by Combined Disruption of MET and EGFR Signaling. Hepatology :
Koral, Kelly; Paranjpe, Shirish; Bowen, William C et al. (2015) Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma. Hepatology 61:537-47
Kang, Liang-I; Isse, Kumiko; Koral, Kelly et al. (2015) Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1. Lab Invest 95:1117-29
Michalopoulos, George K; Khan, Zahida (2015) Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease. Gastroenterology 149:876-882
Norris, Callie A; He, Mu; Kang, Liang-I et al. (2014) Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One 9:e96053
Bhave, Vishakha S; Mars, Wendy; Donthamsetty, Shashikiran et al. (2013) Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex. Am J Pathol 183:153-9
Nejak-Bowen, Kari N; Orr, Anne V; Bowen Jr, William C et al. (2013) Gliotoxin-induced changes in rat liver regeneration after partial hepatectomy. Liver Int 33:1044-55
Donthamsetty, Shashikiran; Bhave, Vishakha S; Mars, Wendy M et al. (2013) Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. PLoS One 8:e74625
Hattoum, Alex; Rubin, Erin; Orr, Anne et al. (2013) Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure. Hum Pathol 44:743-9
Nejak-Bowen, Kari; Orr, Anne; Bowen Jr, William C et al. (2013) Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy. PLoS One 8:e59836

Showing the most recent 10 out of 139 publications